Platinum Investment Management LTD Aslan Pharmaceuticals LTD Transaction History

Platinum Investment Management LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$0.74 - $1.22 $548,568 - $904,396	-741,309 Reduced 83.59%	145,558 $131,000
Q2 2021 Aug 11, 2021	BUY	$2.5 - $3.72 $929,707 - $1.38 Million	371,883 Added 72.21%	886,867 $2.93 Million
Q4 2020 Feb 12, 2021	BUY	$1.54 - $2.22 $135,278 - $195,011	87,843 Added 20.57%	514,984 $942,000
Q3 2020 Nov 13, 2020	BUY	$1.41 - $2.04 $16,484 - $23,849	11,691 Added 2.81%	427,141 $812,000
Q2 2019 Aug 14, 2019	BUY	$2.91 - $4.5 $78,730 - $121,747	27,055 Added 6.97%	415,450 $1.28 Million
Q1 2019 May 15, 2019	BUY	$3.1 - $4.8 $322,090 - $498,720	103,900 Added 36.52%	388,395 $1.67 Million
Q2 2018 Aug 15, 2018	BUY	$5.48 - $10.24 $1.56 Million - $2.91 Million	284,495 New	284,495 $2.53 Million

Ticker ASLN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,744,704
Market Cap $41.8M
Description
ASLAN Pharmaceuticals Limited, a clinical-stage immunology focused biopharmaceutical company, engages in developing various treatments to transform the lives of patients. The company's clinical portfolio comprises ASLAN004, a monoclonal therapy that is being developed in atopic dermatitis and other immunology indications; and ASLAN003, a small-m...

Get notified when there are updates to the investment portfolio of Platinum Investment Management LTD, based on Form 13F filings with the SEC.

Stay updated on Platinum Investment Management LTD with notifications on news.